Immune signatures, testing, and management of febrile neutropenia in pediatric cancer patients
Sign Up to like & getrecommendations! Published in 2023 at "Expert Review of Clinical Immunology"
DOI: 10.1080/1744666x.2023.2168646
Abstract: ABSTRACT Introduction Infectious complications, particularly invasive bacterial and fungal infections, are still a major cause of morbidity in pediatric cancer patients and are associated with significant mortality. Over the last few years, there has been… read more here.
Keywords: pediatric cancer; immune signatures; cancer patients; testing management ... See more keywords
Physician perspectives on Lp(a) testing and management in patients with cardiovascular disease: interviews from seven countries across five world health organization regions from INTERASPIRE.
Sign Up to like & getrecommendations! Published in 2025 at "European journal of preventive cardiology"
DOI: 10.1093/eurjpc/zwaf527
Abstract: AIMS Lipoprotein(a) (Lp(a)) is a genetic causal risk factor for atherosclerotic cardiovascular disease (ASCVD), irrespective of ancestry. INTERASPIRE is an international cohort study of secondary prevention conducted in 14 countries from all 6 WHO regions.… read more here.
Keywords: perspectives testing; physician perspectives; cardiovascular disease; testing management ... See more keywords